{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:26:28Z","timestamp":1790022388800,"version":"4.0.1"},"reference-count":41,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T00:00:00Z","timestamp":1776038400000},"content-version":"unspecified","delay-in-days":102,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["ASHE"],"published-print":{"date-parts":[[2026]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"S2732494X26103416_as1\">\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>This study\u00a0evaluates the impact of the COVID-19 pandemic on the profile of bacterial resistance in healthcare-associated lower respiratory\u00a0tract infections (HAI\/LRTI), in an intensive care unit.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26103416_as2\">\n                    <jats:title>Setting:<\/jats:title>\n                    <jats:p>City of Bel\u00e9m-PA.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26103416_as3\">\n                    <jats:title>Design:<\/jats:title>\n                    <jats:p>This is a retrospective and analytical cross-sectional study, in which the resistance profile of HAI\/LRTI bacterial isolates was evaluated over 2018\u20132022.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26103416_as4\">\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The review of HAI notifications revealed 330 lower respiratory tract infections during the study period. The bacteria with a significant change in the resistance profile between the period pre-COVID and the post-COVID periods were\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      = .011),\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      &lt; .001) and\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      = .001), with increased profiles multidrug-resistant, and extensively drug-resistant, and strains with pandrug-resistant profile, in 2020 and 2021. In the analysis by antibiotic class, there was a significant increase in\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      resistance to carbapenems and\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      resistance to carbapenems.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"S2732494X26103416_as5\">\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>\n                      Comparing the periods, there was an emergence of\n                      <jats:italic>K. pneumoniae<\/jats:italic>\n                      resistant to aminoglycosides and carbapenems; of\n                      <jats:italic>P. aeruginosa<\/jats:italic>\n                      with tendency to resistance to aminoglycoside, carbapenem, 4th generation cephalosporin and anti-pseudomonal penicillin + beta-lactamase inhibitor; of\n                      <jats:italic>A. baumannii<\/jats:italic>\n                      resistant to aminoglycoside, carbapenem, quinolone, anti-pseudomonal penicillin + beta-lactamase inhibitor and penicillin + beta-lactamase inhibitor and 4th generation cephalosporin.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1017\/ash.2026.10341","type":"journal-article","created":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:24:56Z","timestamp":1776072296000},"source":"Crossref","is-referenced-by-count":1,"title":["Antimicrobial resistance before and after the COVID-19 pandemic in Northern Brazil"],"prefix":"10.1017","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7222-237X","authenticated-orcid":false,"given":"Jos\u00e9 Eudes de Carvalho","family":"Neri","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03q9sr818","id-type":"ROR","asserted-by":"publisher"}],"name":"Tropical Diseases Graduate Program"},{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Association of Intensive Care Medicine"},{"name":"Brazilian Company of Hospital Services (EBSERH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2156-0771","authenticated-orcid":false,"given":"Julius Caesar Mendes Soares","family":"Monteiro","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03q9sr818","id-type":"ROR","asserted-by":"publisher"}],"name":"Tropical Diseases Graduate Program"},{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Company of Hospital Services (EBSERH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena Luciane Martins","family":"Rodrigues","sequence":"additional","affiliation":[{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Company of Hospital Services (EBSERH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar de Brito","family":"Sobrinho","sequence":"additional","affiliation":[{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Association of Intensive Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiane Guimar\u00e3es","family":"Monte","sequence":"additional","affiliation":[{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Association of Intensive Care Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Carolina Paes","family":"Boulhosa","sequence":"additional","affiliation":[{"name":"Federal University of Par\u00e1"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafaela Caroline Amador","family":"Ferreira","sequence":"additional","affiliation":[{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Company of Hospital Services (EBSERH)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita Catarina Medeiros","family":"Sousa","sequence":"additional","affiliation":[{"id":[{"id":"https:\/\/ror.org\/03q9sr818","id-type":"ROR","asserted-by":"publisher"}],"name":"Tropical Diseases Graduate Program"},{"name":"Federal University of Par\u00e1"},{"name":"Brazilian Company of Hospital Services (EBSERH)"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2026,4,13]]},"reference":[{"key":"S2732494X26103416_ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2022.105409"},{"key":"S2732494X26103416_ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41579-020-00459-7"},{"key":"S2732494X26103416_ref18","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"S2732494X26103416_ref37","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2020.575536"},{"key":"S2732494X26103416_ref9","unstructured":"9. WHO. Global report on infection prevention and control. 2022b. http:\/\/apps.who.int\/bookorders. Accessed August 20, 2023."},{"key":"S2732494X26103416_ref7","unstructured":"7. Tacconelli, E , Carrara, E , Savoldi, A , Kattula, D , Burkert, F. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. 2017. http:\/\/www.cdc.gov\/drugresistance\/threat-report-2013\/. Accessed August 15, 2023."},{"key":"S2732494X26103416_ref31","unstructured":"31. WHO. Global action plan on antimicrobial resistance: options for establishing a global development and stewardship framework to support the development, control, distribution and appropriate use of new antimicrobial medicines, diagnostic tools, vaccines and other interventions: report by the Secretariat. 2016. https:\/\/apps.who.int\/iris\/handle\/10665\/252682. Accessed August 15, 2023."},{"key":"S2732494X26103416_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2021.09.018"},{"key":"S2732494X26103416_ref34","volume-title":"Antibi\u00f3ticos e quimioter\u00e1picos para o cl\u00ednico","author":"Tavares","year":"2014"},{"key":"S2732494X26103416_ref15","first-page":"1","article-title":"Emergence of high antimicrobial resistance among critically ill patients with hospital-acquired infections in a tertiary care hospital","volume":"58","author":"Warda","year":"2022","journal-title":"Medicina"},{"key":"S2732494X26103416_ref35","doi-asserted-by":"publisher","DOI":"10.15620\/cdc:117915"},{"key":"S2732494X26103416_ref36","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad260"},{"key":"S2732494X26103416_ref19","first-page":"663","article-title":"Antimicrobial resistance and the COVID-19 pandemic: a double threat","volume":"98","author":"Kanungo","year":"2020","journal-title":"Bull World Health Organ"},{"key":"S2732494X26103416_ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2022.12.022"},{"key":"S2732494X26103416_ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-022-01113-y"},{"key":"S2732494X26103416_ref40","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkab300"},{"key":"S2732494X26103416_ref21","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S299774"},{"key":"S2732494X26103416_ref32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106324"},{"key":"S2732494X26103416_ref24","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9092744"},{"key":"S2732494X26103416_ref1","unstructured":"1. WHO. COVID-19 dashboard Data World Cases Deaths Vaccines Variants Data About More resources Number of COVID-19 cases reported to WHO (cumulative total). 2024. https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c. Accessed March 1, 2025."},{"key":"S2732494X26103416_ref30","doi-asserted-by":"publisher","DOI":"10.3855\/jidc.14404"},{"key":"S2732494X26103416_ref5","unstructured":"5. WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. 2017. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed. Accessed August 10, 2023."},{"key":"S2732494X26103416_ref33","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10030495"},{"key":"S2732494X26103416_ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.106179"},{"key":"S2732494X26103416_ref22","unstructured":"22. WHO. Clinical management of COVID-19 Interim Guidance - May 2020. 2020. https:\/\/www.who.int\/publications-detail\/clinical-management-of-covid-19. Accessed August 15, 2023."},{"key":"S2732494X26103416_ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-020-05374-z"},{"key":"S2732494X26103416_ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa530"},{"key":"S2732494X26103416_ref6","unstructured":"6. ANVISA. Microbiologia Cl\u00ednica para o Controle de Infec\u00e7\u00e3o Relacionada \u00e0 Assist\u00eancia \u00e0 Sa\u00fade, Brasil, 2020. https:\/\/www.gov.br\/anvisa\/pt-br\/centraisdeconteudo\/publica\u00e7\u00f5es\/servicosdesaude\/publicacoes\/modulo-10_manual-de-microbiologia.pdf."},{"key":"S2732494X26103416_ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2014.10.004"},{"key":"S2732494X26103416_ref3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics10091080"},{"key":"S2732494X26103416_ref28","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.1585"},{"key":"S2732494X26103416_ref23","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191911931"},{"key":"S2732494X26103416_ref8","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S177247"},{"key":"S2732494X26103416_ref11","unstructured":"11. Brcast. Redefini\u00e7\u00e3o das categorias dos testes de sensibilidade S, I e R. 2019. https:\/\/brcast.org.br\/wp-content\/uploads\/2022\/09\/Redefinic%CC%A7a%CC%83o-das-Categorias-dos-Testes-de-Sensibil-S-I-e-R.pdf. Accessed August 10, 2023."},{"key":"S2732494X26103416_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-28945-0.00028-4"},{"key":"S2732494X26103416_ref39","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics12030537"},{"key":"S2732494X26103416_ref4","unstructured":"4. WHO. Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report 2022. 2022. https:\/\/www.who.int\/publications\/book-orders. Accessed March 3, 2025."},{"key":"S2732494X26103416_ref41","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajic.2020.09.013"},{"key":"S2732494X26103416_ref29","doi-asserted-by":"publisher","DOI":"10.1089\/mdr.2021.0231"},{"key":"S2732494X26103416_ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s13756-022-01085-z"},{"key":"S2732494X26103416_ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.05.013"}],"container-title":["Antimicrobial Stewardship &amp; Healthcare Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S2732494X26103416","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T09:25:15Z","timestamp":1776072315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S2732494X26103416\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026]]}},"alternative-id":["S2732494X26103416"],"URL":"https:\/\/doi.org\/10.1017\/ash.2026.10341","relation":{},"ISSN":["2732-494X"],"issn-type":[{"value":"2732-494X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"e102"}}